[Efects of Inhibiting miR-155 Expression on the Proliferation and Apoptosis of Leukemia THP-1 Cells]

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• MicroRNA-155 (miR-155) plays a role in cell proliferation and apoptosis.
• Dysregulation of miR-155 is implicated in various cancers, including acute myeloid leukemia (AML).
• Understanding miR-155's regulatory mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the impact of miR-155 inhibitor transfection on THP-1 cell proliferation and apoptosis.
• To elucidate the molecular mechanisms by which miR-155 affects its downstream targets, including SHIP1 and the PI3K/AKT pathway.
• To evaluate the therapeutic potential of miR-155 inhibition in AML.

Main Methods:

• Transfection of THP-1 cells with a miR-155 inhibitor.
• Quantitative real-time polymerase chain reaction (RT-PCR) for gene expression analysis.
• Cell Counting Kit-8 (CCK-8) assay for proliferation assessment.
• Flow cytometry for apoptosis detection.
• Western blot analysis for protein expression levels (SHIP1, TAKT, pAKT).

Main Results:

• miR-155 expression was significantly reduced in THP-1 cells transfected with the miR-155 inhibitor.
• Inhibition of miR-155 significantly increased the apoptosis rate of THP-1 cells.
• miR-155 inhibition led to increased SHIP1 protein levels without altering mRNA levels, suggesting post-transcriptional regulation.
• Protein levels of pAKT were significantly reduced, while TAKT levels remained unchanged.
• miR-155 inhibition impaired the downstream PI3K/AKT signaling pathway.

Conclusions:

• miR-155 inhibition promotes THP-1 cell apoptosis by increasing SHIP1 protein content and inhibiting the PI3K/AKT signaling pathway.
• These findings suggest that miR-155 inhibition could be a potential therapeutic strategy for acute myeloid leukemia (AML).
• Further research is warranted to explore the clinical applicability of miR-155 inhibitors in AML treatment.